Study of Serum IgM, IgG, IL-37 Levels and IL-37 Gene Polymorphism in Women Infected with Trichomonas Vaginalis in Baqubah City

Noor Ghassan, Maha Falih Nazzal and Ibtisam Badday Hassan

References:

1. J. Rowley, S. Hoorn, E. Korenromp, N. Low, M. Unemo, L. J. Abu-Raddad, and M. M. Taylor, "Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016," Bull. World Health Organ., vol. 97, no. 8, pp. 548-562, 2018.
2. S. K. Al-Hadraawy, S. M. Al-Kafagy, and K. A. Al-Hadraawy, "Molecular and immunological study for detection of IL-6 in men infected with Trichomonas vaginalis parasite in Al-Najaf province, Iraq," Al-Qadisiya Med. J., vol. 10, no. 8, pp. 144-148, 2014.
3. E. J. Saheb, R. H. Kuba, K. H. Zghair, and I. Musa, "A comparison between Trichomoniasis infection and other vaginal infection among females in Baghdad Governorate, Iraq," Iraqi J. Sci., vol. 57, no. 1C, pp. 545-551, 2016.
4. M. J. Patil, J. M. Nagamoti, and S. C. Metgud, "Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, InPouch TV culture system, and PCR," J. Global Infect. Dis., vol. 4, no. 1, pp. 22-25, 2012.
5. W. Abou-Kamar, A. Abdel-Mageid, H. El-Nahas, R. Atia, and N. El-Tantawy, "Genetic relatedness of Trichomonas vaginalis isolates to the clinical variability," iMedPub J., vol. 1, no. 1, p. 103, 2017.
6. G. B. Vaca, "Topical use of monoclonal antibodies as a multipurpose prevention technology offering contraception and decreased transmission of HIV-1 and Trichomonas vaginalis," Boston Univ., 2020.
7. M. Nemati, N. Malla, M. Yadav, A. Khorramdelazad, and A. Jafarzabeh, "Humoral and cell mediated immune response against trichomoniasis," Parasite Immunol., vol. 40, no. 3, pp. 1-11, 2018.
8. H. Kattawy, A. Ebrahim, O. Abdelwahab, and A. Basheir, "Interleukin-37 has a promising cardioprotective effect on isoproterenol-induced myocardial infarction," Int. J. Morphol., vol. 41, pp. 1427-1438, 2023, doi: 10.4067/S0717-95022023000501427.
9. M. Younis, "Trichomonas vaginalis parasite and its relationship with some inflammatory cytokines," J. Sci. Med. Life, vol. 2, no. 3, 2024.
10. M. Sutton, M. Madeline, E. H. Sternberg, and G. Koumans, "The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004," Clin. Infect. Dis., vol. 45, no. 10, pp. 1319-1326, 2007.
11. R. C. Tine, L. Dia, K. Sylla, D. Sow, S. Lelo, and C. T. Ndour, "Trichomonas vaginalis and Mycoplasma infections among women with vaginal discharge at Fann teaching hospital in Senegal," Trop. Parasitol., vol. 9, pp. 45-53, 2019.
12. E. Younis and A. Elamami, "Trichomonas vaginalis infection in women with type 2 diabetes mellitus and vaginal discharge in Benghazi, Libya," Ibnosina J. Med. Biomed. Sci., vol. 8, no. 4, pp. 109-113, 2016.
13. M. Alardi, "Seroprevalence and risk factors of Trichomonas vaginalis among couples in Al-Hamza city, Iraq," Al-Kufa Univ. J. Biol., vol. 13, pp. 35-44, 2021.
14. N. Malla, K. Goyal, R. S. Dhanda, and M. Yadav, "Immunity in urogenital protozoa," Parasite Immunol., vol. 36, pp. 400-408, 2014.
15. B. G. Giulia and T. Tiana, "Infinity war: Trichomonas vaginalis and interactions with host immune response," Microb. Cell, vol. 10, no. 5, pp. 103-116, 2023.
16. E. Michaud, C. Mastrandrea, N. Rochereau, and S. Paul, "Human secretory IgM: an elusive player in mucosal immunity," Trends Immunol., vol. 41, no. 2, pp. 141-156, 2020.
17. H. Saab, A. Zangana, and H. Al-Doori, "The effect of infection with some intestinal parasites on some immune parameters," Int. J. Pharm. Biomed. Sci., vol. 4, 2024, doi: 10.47191/ijpbms/v4-i3-16.
18. G. Dekkers, T. Rispens, and G. Vidarsson, "Novel concepts of altered immunoglobulin G galactosylation in autoimmune diseases," Front. Immunol., vol. 9, p. 553, 2018.
19. L. Shamoun, B. Kolodziej, R. Andersson, and J. Dimberg, "Protein expression and genetic variation of IL32 and association with colorectal cancer in Swedish patients," Anticancer Res., vol. 38, pp. 321-328, 2018.
20. G. Allam, A. M. Gaber, S. I. Othman, and A. Abdel-Moneim, "The potential role of interleukin-37 in infectious diseases," Int. Rev. Immunol., vol. 39, pp. 3-10, 2020.
21. B. Kang, S. Cheng, J. Peng, J. Yan, and S. Zhang, "Interleukin-37 gene variants segregated anciently coexist during hominid evolution," Eur. J. Hum. Genet., vol. 23, no. 10, pp. 1392-1398, 2015.
22. H. Jia, J. Liu, and B. Han, "Reviews of interleukin-37: functions, receptors, and roles in diseases," Biomed. Res. Int., vol. 2018, p. 1, 2018.
23. S. Özgüçlü, T. Duman, F. S. Ateş, O. Küçükşahin, S. Çolak, and U. Ölmez, "Serum interleukin-37 level and interleukin-37 gene polymorphism in patients with Behçet disease," Clin. Rheumatol., vol. 38, pp. 495-502, 2019.
24. X. Y. Lin, X. J. Guo, Y. Z. He, S. F. Hou, H. B. Zhu, and Y. Cheng, "Association between interleukin 37 (rs3811047) polymorphism and multiple autoimmune diseases in a Chinese population: a PRISMA-compliant meta-analysis," Medicine (Baltimore), vol. 97, no. e0386, 2018.